In a study examining the prognostic value of certain biomarker proteins for coronary artery disease patients, circulating osteoglycin, whose expression was elevated in vulnerable atherosclerotic plaques, was suggested as a promising biomarker of adverse cardiovascular events [32]. The gene discussed is OGN; the disease is coronary artery disorder.